logo
ProjectUnder Appraisal

TECHEU VD NMD PHARMA (BIOTECH ACT)

The status, timeline and source of this project. A free account opens every field.

Source: European Investment Bank (EIB)

The project finances research, development and clinical activities for innovative therapies addressing rare neuromuscular disorders, based on a mechanism that enhances neuromuscular transmission and muscle activation through modulation of the skeletal-muscle chloride channel ClC-1.

Status
Prospective
Sector
Industry
Location
Denmark
Updated
19 Nov 2026
Source
European Investment Bank (EIB)

ConstructChat

Ask ConstructChat about TECHEU VD NMD PHARMA (BIOTECH ACT)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “TECHEU VD NMD PHARMA (BIOTECH ACT)” is an infrastructure initiative in the Industry sector, located in Denmark. Taiyo aggregates data on it from European Investment Bank (EIB).

Participants

Not available for this record.

Status

Original status

under appraisal

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The project finances research, development and clinical activities for innovative therapies addressing rare neuromuscular disorders, based on a mechanism that enhances neuromuscular transmission and muscle activation through modulation of the skeletal-muscle chloride channel ClC-1.

Original sector

Industry

Location

Country

Denmark

Source

Source

European Investment Bank (EIB)

URL

More Details

Record type

Project

Article published date

2026-05-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project